Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.22−0.03 (-13.03%)
Close on Nov 16, 2026Market cap $1.41MP/E –Yield –
Co-Diagnostics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Co-Diagnostics's gross profit for the twelve months ending Jun 30, 2026 was $313.64K, down 21.1% year over year. For fiscal 2025 it was $400.11K, down 86.3% from the year before. The highest annual figure on record is $86.31M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $400.11K | -86.3% |
| FY2024 | Dec 31, 2024 | $2.92M | +11.0% |
| FY2023 | Dec 31, 2023 | $2.63M | -90.9% |
| FY2022 | Dec 31, 2022 | $28.74M | -66.7% |
| FY2021 | Dec 31, 2021 | $86.31M | +48.9% |
| FY2020 | Dec 31, 2020 | $57.96M | +56424.0% |
| FY2019 | Dec 31, 2019 | $102.54K | +236.0% |
| FY2018 | Dec 31, 2018 | $30.52K | +314.7% |
| FY2017 | Dec 31, 2017 | $7.36K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $120.83K | -7.6% |
| Q1 FY2026 | Mar 31, 2026 | -$47.81K | -266.7% |
| Q4 FY2025 | Dec 31, 2025 | $121.53K | – |
| Q3 FY2025 | Sep 30, 2025 | $119.10K | -65.4% |
| Q2 FY2025 | Jun 30, 2025 | $130.80K | -94.6% |
| Q1 FY2025 | Mar 31, 2025 | $28.69K | -87.7% |
| Q4 FY2024 | Dec 31, 2024 | -$105.74K | -118.0% |
| Q3 FY2024 | Sep 30, 2024 | $343.74K | -84.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.44M | – |
| Q1 FY2024 | Mar 31, 2024 | $233.35K | +134.0% |
| Q4 FY2023 | Dec 31, 2023 | $587.34K | -33.7% |
| Q3 FY2023 | Sep 30, 2023 | $2.20M | -49.1% |
| Q2 FY2023 | Jun 30, 2023 | -$261.29K | -106.4% |
| Q1 FY2023 | Mar 31, 2023 | $99.72K | -99.5% |
| Q4 FY2022 | Dec 31, 2022 | $885.71K | -95.1% |
| Q3 FY2022 | Sep 30, 2022 | $4.33M | -83.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.11M | -83.5% |
| Q1 FY2022 | Mar 31, 2022 | $19.42M | +15.9% |
| Q4 FY2021 | Dec 31, 2021 | $17.91M | -21.5% |
| Q3 FY2021 | Sep 30, 2021 | $26.79M | +67.5% |
| Q2 FY2021 | Jun 30, 2021 | $24.85M | +37.6% |
| Q1 FY2021 | Mar 31, 2021 | $16.75M | +1470.3% |
| Q4 FY2020 | Dec 31, 2020 | $22.83M | +40846.5% |
| Q3 FY2020 | Sep 30, 2020 | $16.00M | +75829.0% |
| Q2 FY2020 | Jun 30, 2020 | $18.06M | +79254.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.07M | +36086.8% |
| Q4 FY2019 | Dec 31, 2019 | $55.76K | +3793.9% |
| Q3 FY2019 | Sep 30, 2019 | $21.07K | +117.3% |
| Q2 FY2019 | Jun 30, 2019 | $22.77K | +134.8% |
| Q1 FY2019 | Mar 31, 2019 | $2.95K | -69.6% |
| Q4 FY2018 | Dec 31, 2018 | $1.43K | -44.9% |
| Q3 FY2018 | Sep 30, 2018 | $9.70K | +273.2% |
| Q2 FY2018 | Jun 30, 2018 | $9.70K | +348.1% |
| Q1 FY2018 | Mar 31, 2018 | $9.70K | – |
| Q4 FY2017 | Dec 31, 2017 | $2.60K | – |
| Q3 FY2017 | Sep 30, 2017 | $2.60K | – |
| Q2 FY2017 | Jun 30, 2017 | $2.16K | – |
See a number that looks wrong?